Bioalpha Holdings Bhd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioalpha Holdings Bhd with three other
pharmaceutical manufacturers in Asia:
Mezzion Pharma Co Ltd
of KOREA (SOUTH)
sales of 18.93 billion Korean Won [US$17.15 million]
of which 94%
was Feed Segment),
Traphaco High Tech Joint Stock Co
(354.08 billion Vietnamese Dong [US$15.33 million]
Yung Zip Chemical Ind.Co.,Ltd
based in TAIWAN
(416.84 million Taiwanese Dollars [US$14.89 million]
Bioalpha Holdings Bhd reported sales of 63.67 million Malaysian Ringgits (US$15.71 million)
December of 2019.
decrease of 9.2%
versus 2018, when the company's sales were 70.09 million Malaysian Ringgits.
Contributing to the drop in overall sales was the 23.2% decline
in Manufacturing and Sale of Finished Health , from 47.55 million Malaysian Ringgits to 36.53 million Malaysian Ringgits.
There were also decreases in sales in
Retail Pharmacies (down 17.9% to 27.14 million Malaysian Ringgits)